CareDx (CDNA)
(Delayed Data from NSDQ)
$7.98 USD
-0.25 (-3.04%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $7.90 -0.08 (-1.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
CareDx (CDNA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$12.00 | $15.00 | $9.00 | 45.81% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for CareDx comes to $12.00. The forecasts range from a low of $9.00 to a high of $15.00. The average price target represents an increase of 45.81% from the last closing price of $8.23.
Analyst Price Targets (5 )
Broker Rating
CareDx currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 42.86% and 14.29% of all recommendations. A month ago, Strong Buy made up 42.86%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/17/2024 | Stephens | Mason Carrico | Strong Buy | Strong Buy |
2/29/2024 | Raymond James | Andrew Cooper | Moderate Buy | Moderate Buy |
2/16/2024 | Craig-Hallum | Alex Nowak | Hold | Hold |
1/7/2024 | BTIG | Mark Massaro | Hold | Hold |
11/9/2023 | H.C. Wainwright & Co. | Yi Chen | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 7 |
Average Target Price | $12.00 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 91 of 252 |
Current Quarter EPS Est: | -0.19 |